Medical research

'Expansion pathology' method could mean earlier intervention

(HealthDay)—A new method, called expansion pathology (ExPath), which is a clinically optimized form of expansion microscopy (ExM), can be used for pathology and clinical research, according to a report published online ...

Genetics

Worldwide study demonstrates accuracy of genetic analyses

Physicians envision a future in which genomic data from patients is heavily used to manage care—but experts have questioned the accuracy and reliability of these analyses. Now, a study by 150 researchers in 12 countries ...

Oncology & Cancer

Researchers discover new combination therapy to kill cancer

Cancer is the leading cause of death in Canada and is responsible for about 30% of all deaths, according to the Canadian Cancer Society. Despite the urgent need for new and effective drugs, it remains extremely difficult ...

page 1 from 3

Nature Biotechnology

Nature Biotechnology (Nat Biotechnol; ISSN 1087-0156) is an academic journal covering the science and business of biotechnology.

Nature Biotechnology is a continuation of Bio/technology (Biotechnology (NY); ISSN 0733-222X), which was founded in 1983 and renamed in 1996. It is published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. Like other Nature journals, there is no external Editorial Board; editorial decisions are made by an in-house team, although peer review by external expert referees forms a part of the review process.

Its 2005 impact factor was 22.7, making it the highest cited research journal in the category of biotechnology and applied microbiology, and one of the 20 most highly cited scientific journals. In comparison, the impact factors of general science journals Science and Nature for the same period were 30.927 and 29.273, respectively.

The current editor of Nature Biotechnology is Andrew Marshall. The founding editor of Bio/technology was Christopher Edwards.

This text uses material from Wikipedia, licensed under CC BY-SA